---
title: "Vertex Pharmaceuticals Currently Down Seven Consecutive Days, on Pace for Longest Losing Streak Since August 2021 — Data Talk"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292789554.md"
description: "Vertex Pharmaceuticals (VRTX) is experiencing its longest losing streak since August 2021, with seven consecutive days of declines totaling a 10.34% drop. Trading at $474.81, the stock is on pace for its largest percentage decrease since July 2026 and has fallen from its all-time high of $529.59. Despite being down 4.41% month-to-date, it remains up 4.73% year-to-date."
datetime: "2026-07-15T15:11:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292789554.md)
  - [en](https://longbridge.com/en/news/292789554.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292789554.md)
---

# Vertex Pharmaceuticals Currently Down Seven Consecutive Days, on Pace for Longest Losing Streak Since August 2021 — Data Talk

Vertex Pharmaceuticals Incorporated (VRTX) is currently at $474.81, down $1.50 or 0.31%

\--Would be lowest close since June 23, 2026, when it closed at $468.42

\--On pace for largest percent decrease since July 14, 2026, when it fell 0.82%

\--Currently down seven consecutive days; down 10.34% over this period

\--Longest losing streak since Aug. 16, 2021, when it fell for seven straight trading days

\--Worst seven day stretch since the seven days ending Aug. 13, 2025, when it fell 16.17%

\--Down 4.41% month-to-date

\--Up 4.73% year-to-date

\--Down 10.34% from its all-time closing high of $529.59 on July 6, 2026

\--Up 1.12% from 52 weeks ago (July 16, 2025), when it closed at $469.55

\--Down 10.34% from its 52-week closing high of $529.59 on July 6, 2026

\--Up 29.54% from its 52-week closing low of $366.54 on Aug. 8, 2025

\--Traded as low as $469.60; lowest intraday level since June 23, 2026, when it hit $463.76

\--Down 1.41% at today's intraday low

\--10th least active stock in the Nasdaq 100 today

All data as of 10:45:14 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 15, 2026 11:02 ET (15:02 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

### Related Stocks

- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)
- [.NDX.US](https://longbridge.com/en/quote/.NDX.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Vertex Pharmaceuticals just made a $10 billion acquisition worth watching](https://longbridge.com/en/news/293142937.md)
- [Vertex Pharmaceuticals (VRTX) Stock Trades Below Fair Value After Deal Plans](https://longbridge.com/en/news/293268909.md)
- [$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/292820592.md)
- [BMO Capital Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)](https://longbridge.com/en/news/292497368.md)
- [Scribe Therapeutics - IPO Price Expected Between $13 And $15 Per Share - SEC Filing](https://longbridge.com/en/news/293206787.md)